Researcher
Ann Smeets
- Disciplines:Morphological sciences, Oncology, Orthopaedics, Surgery, Nursing
Affiliations
- Surgical Oncology (Division)
Member
From1 Jan 2012 → Today
Projects
1 - 10 of 10
- iSurvive-Mind Helpt het geheugen van (ex-)kankerpatiëntenFrom1 May 2023 → TodayFunding: Provinces
- The enigma of subjective lymphedema: Why do patients report lymphedema after breast cancer treatment without an objective measurable swelling? The role of sensory processing and subclinical lymphedema – LymphSens TrialFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Impact of adiposity and lifestyle on breast cancer biology and treatment response.From7 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Identifying prognostic variables for persistent upper limb dysfunctions after breast cancer treatment: body functions, personal and environmental factors according to the International Classification of Functioning, Disease and Health (ICF)From25 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Identifying prognostic variables for persistent upper limb dysfunctions after breast cancer treatment: body functions, personal and environmental factors according to the International Classification of Functioning, Disease and Health (ICF)From1 Oct 2021 → TodayFunding: BOF - projects
- Connecting Single-cell Immune Profiling in Peripheral Blood with Intratumoral T Cell Expansion in Breast Cancer Upon Checkpoint ImmunotherapyFrom24 Aug 2021 → TodayFunding: FWO fellowships
- A mindfulness-based intervention as candidate to reduce cognitive impairment and recover brain changes after breast cancer treatment.From2 Jan 2019 → TodayFunding: FWO Strategic Basic Research Grant
- What causes cognitive decline after treatment for breast cancer? A multiparametric neuroimaging studyFrom4 Sep 2017 → 14 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Role of combined chemo- and immunotherapy in early breast cancerFrom1 Oct 2016 → 30 Sep 2020Funding: Nonprofit institution or equivalents
- Effect of pembrolizumab on biomarkers related to intratumoral immunity, proliferation and apoptosis in early breast cancerFrom1 Oct 2016 → 15 Nov 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 145
- A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry(2023)
Authors: Thaïs Baert, Diether Lambrechts, Ann Smeets, Hans Wildiers
- Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer(2023)
Authors: Tatjana Geukens, Maxim De Schepper, François Richard, Karen Van Baelen, Ha Linh Nguyen, Anirudh Pabba, Ann Smeets, Patrick Neven, Hans Wildiers, Wouter Van Den Bogaert, et al.
Pages: 152 - 160 - The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study(2023)
Authors: Patrick Neven, Eva Oldenburger, Sileny Han, Chantal Van Ongeval, Ann Smeets, Hans Wildiers, Nele Laudus
Pages: E273 - E280 - Obesity-associated changes in molecular biology of primary breast cancer(2023)
Authors: Ha Linh Nguyen, Tatjana Geukens, Maxim De Schepper, Stefan Naulaerts, Patrick Neven, Karen Van Baelen, Hanne Vos, Hans Wildiers, Beppe Floris, Abhishek Garg, et al.
- Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer (vol 33, pg 769, 2022)(2023)
Authors: François Richard, Chantal Van Ongeval, Maxim De Schepper, Ann Smeets, Hans Wildiers, Patrick Neven, Christine Desmedt
Pages: 326 - 326 - Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1(+) T lymphocyte niches through a feed-forward loop (vol 40, pg 1600, 2022)(2023)
Authors: Yichao Hua, Ann Smeets, David Nittner, Francesca Bosisio, Diether Lambrechts, Chris Marine, Gabriele Bergers
Pages: 226 - 226 - Retrospective Cohort Study of Practical Applications of Paramagnetic Seed Localisation in Breast Carcinoma and Other Malignancies(2022)
Authors: Chantal Van Ongeval, Patrick Neven, Sileny Han, Annouschka Laenen, Ann Smeets
- Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1(+) T lymphocyte niches through a feed-forward loop(2022)
Authors: Yichao Hua, Gerlanda Vella, Ann Smeets, David Nittner, Francesca Bosisio, Beppe Floris, Diether Lambrechts, Chris Marine, Susan Schlenner, Gabriele Bergers
Pages: 1600 - + - Impact of baseline telomere length on survival and chemotherapy related toxicity in breast cancer patients receiving (neo)adjuvant anthracycline containing chemotherapy(2022)
Authors: Sigrid Hatse, Patrick Neven, Ann Smeets, Annouschka Laenen, Hans Wildiers
- Dynamic alterations of immunosenescence-related genes in older women with breast cancer receiving chemotherapy: A prospective study(2022)
Authors: Cindy Kenis, Ann Smeets, Annouschka Laenen, Hans Wildiers, Sigrid Hatse